Conversion From a Calcineurin Inhibitor-Based Immunosuppressive Regimen to Everolimus in Renal Transplant Recipients: Effect on Renal Function and Proteinuria
Authors:
- 17 April 2007
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 39 (3) , 591-593
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Post-transplant de novo malignancies in renal transplant recipients: the past and presentTransplant International, 2006
- Improved Renal Function after Conversion from Tacrolimus/Sirolimus to Tacrolimus/Mycophenolate Mofetil in Kidney Transplant RecipientsTransplantation, 2006
- Complete Avoidance of Calcineurin Inhibitors in Renal Transplantation: A Randomized Trial Comparing Sirolimus and TacrolimusAmerican Journal of Transplantation, 2006
- Sirolimus-Associated Heavy Proteinuria in a Renal Transplant Recipient: Evidence for a Tubular MechanismAmerican Journal of Transplantation, 2006
- Conversion to Sirolimus From Cyclosporine May Induce Nephrotic Proteinuria and Progressive Deterioration of Renal Function in Chronic Allograft Nephropathy PatientsTransplantation Proceedings, 2006
- Proteinuria Following a Switch from Calcineurin Inhibitors to SirolimusTransplantation, 2005
- Posttransplantation chronic renal damage in nonrenal transplant recipientsKidney International, 2005
- Everolimus versus Mycophenolate Mofetil in the Prevention of Rejection in De Novo Renal Transplant Recipients: A 3-Year Randomized, Multicenter, Phase III StudyTransplantation, 2005
- Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol HistologyTransplantation, 2004
- The Natural History of Chronic Allograft NephropathyNew England Journal of Medicine, 2003